Nexosome Oncology focus on the applications of exosome-based diagnostics in the cancer field.
Nexosome Oncology has raised $3.7M in total funding. The most recent round was Seed. The last funding was announced in November 2021.
Nexosome Oncology's investors include OCA Ventures, Keyhorse Capital, VisionTech Partners.
Nexosome Oncology is headquartered in Lexington, United States.
Nexosome Oncology focus on the applications of exosome-based diagnostics in the cancer field.
Nexosome Oncology is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nexosome Oncology — Funding & Investors." VCBacked, November 22, 2021, https://www.vcbacked.co/company/nexosome-oncology. Accessed September 30, 2026.
VCBacked. (2021). Nexosome Oncology — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/nexosome-oncology
{{cite web |title=Nexosome Oncology — Funding & Investors |url=https://www.vcbacked.co/company/nexosome-oncology |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated